The forum came at time when there appears to be little health messaging at the federal level.

The US Department of Health and Human Services granted Novartis with a contract for up to $220 million in 2006 to build a cell culture-based influenza vaccine plant in the US, recognising Novartis ...

See the latest Novartis AG Registered Shares stock price (NOVN:XSWX), related news, valuation, dividends and more to help you make your investing decisions.

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

See the latest Novartis AG ADR stock price (NVS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Two of the world's largest pharmaceutical companies are suing Oklahoma to stop a new state law dealing with a $70 billion ...

The Alzheimer’s Drugs Market is anticipated to experience a compound annual growth rate (CAGR) of approximately 20% over the ...

The Genomics business benefited from 20% volume growth in oncology tests (legacy Tempus clinical testing) and higher average revenue per test, driven by increased Medicare reimbur ...

The global Radioligand Therapy (RLT) market is poised to reach US$13 billion by 2030, expanding at a ~5% CAGR over the ...

Novartis has also announced a novel collaboration with the United States Centers for Medicare and Medicaid Services (CMS) centred around indication-based pricing and outcomes-based payment.

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer ...